108 related articles for article (PubMed ID: 21911541)
21. Osteosarcoma in patients older than 65 years.
Longhi A; Errani C; Gonzales-Arabio D; Ferrari C; Mercuri M
J Clin Oncol; 2008 Nov; 26(33):5368-73. PubMed ID: 18809616
[TBL] [Abstract][Full Text] [Related]
22. Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients.
Wu PK; Chen WM; Chen CF; Lee OK; Haung CK; Chen TH
Jpn J Clin Oncol; 2009 Aug; 39(8):514-22. PubMed ID: 19525290
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for patients with sarcomas of the pelvic bones.
Kawai A; Healey JH; Boland PJ; Lin PP; Huvos AG; Meyers PA
Cancer; 1998 Mar; 82(5):851-9. PubMed ID: 9486573
[TBL] [Abstract][Full Text] [Related]
24. Free osseous and soft tissue surgical margins as prognostic factors in mandibular osteosarcoma.
Granados-Garcia M; Luna-Ortiz K; Castillo-Oliva HA; Villavicencio-Valencia V; Herrera-Gómez A; Mosqueda-Taylor A; Aguilar-Ponce JL; Poitevin-Chacón A
Oral Oncol; 2006 Feb; 42(2):172-6. PubMed ID: 16246617
[TBL] [Abstract][Full Text] [Related]
25. The role of radiotherapy in oseosarcoma.
Schwarz R; Bruland O; Cassoni A; Schomberg P; Bielack S
Cancer Treat Res; 2009; 152():147-64. PubMed ID: 20213389
[TBL] [Abstract][Full Text] [Related]
26. Malignant sarcoma of the pelvic bones: treatment outcomes and prognostic factors vary by histopathology.
Jawad MU; Haleem AA; Scully SP
Cancer; 2011 Apr; 117(7):1529-41. PubMed ID: 21425154
[TBL] [Abstract][Full Text] [Related]
27. Factors affecting the incident juvenile bone tumors in an Austrian case-control study.
Frentzel-Beyme R; Becher H; Salzer-Kuntschik M; Kotz R; Salzer M
Cancer Detect Prev; 2004; 28(3):159-69. PubMed ID: 15225895
[TBL] [Abstract][Full Text] [Related]
28. Ewing's sarcoma and the development of secondary malignancies.
Fuchs B; Valenzuela RG; Petersen IA; Arndt CA; Sim FH
Clin Orthop Relat Res; 2003 Oct; (415):82-9. PubMed ID: 14612633
[TBL] [Abstract][Full Text] [Related]
29. Osteosarcoma in New Zealand 1981-7: an overview.
Mills HJ; Horne G; Devane P
N Z Med J; 1995 Nov; 108(1011):458-9. PubMed ID: 8538963
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in soft tissue sarcomas: a study of 395 patients.
Stefanovski PD; Bidoli E; De Paoli A; Buonadonna A; Boz G; Libra M; Morassut S; Rossi C; Carbone A; Frustaci S
Eur J Surg Oncol; 2002 Mar; 28(2):153-64. PubMed ID: 11884051
[TBL] [Abstract][Full Text] [Related]
31. National Cancer Data Base report on osteosarcoma of the head and neck.
Smith RB; Apostolakis LW; Karnell LH; Koch BB; Robinson RA; Zhen W; Menck HR; Hoffman HT
Cancer; 2003 Oct; 98(8):1670-80. PubMed ID: 14534884
[TBL] [Abstract][Full Text] [Related]
32. Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study.
Nooij MA; Whelan J; Bramwell VH; Taminiau AT; Cannon S; Hogendoorn PC; Pringle J; Uscinska BM; Weeden S; Kirkpatrick A; Glabbeke Mv; Craft AW;
Eur J Cancer; 2005 Jan; 41(2):225-30. PubMed ID: 15661546
[TBL] [Abstract][Full Text] [Related]
33. Synovial sarcoma: the importance of size and location for survival.
Deshmukh R; Mankin HJ; Singer S
Clin Orthop Relat Res; 2004 Feb; (419):155-61. PubMed ID: 15021147
[TBL] [Abstract][Full Text] [Related]
34. Osteosarcoma of the spine: experience in 26 patients treated at the Massachusetts General Hospital.
Schoenfeld AJ; Hornicek FJ; Pedlow FX; Kobayashi W; Garcia RT; DeLaney TF; Springfield D; Mankin HJ; Schwab JH
Spine J; 2010 Aug; 10(8):708-14. PubMed ID: 20650409
[TBL] [Abstract][Full Text] [Related]
35. Induction chemotherapy for bone sarcoma in adults: correlation of results with erbB-4 expression.
Merimsky O; Kollender Y; Issakov J; Inbar M; Flusser G; Benayahu D; Meller I; Bickels J
Oncol Rep; 2003; 10(5):1593-9. PubMed ID: 12883746
[TBL] [Abstract][Full Text] [Related]
36. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
Trovik CS;
Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
[TBL] [Abstract][Full Text] [Related]
37. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
38. Osteosarcoma of the flat bone.
Lee JA; Kim MS; Koh JS; Kim MS; Kim DH; Lim JS; Kong CB; Song WS; Cho WH; Lee SY; Jeon DG
Jpn J Clin Oncol; 2010 Jan; 40(1):47-53. PubMed ID: 19892781
[TBL] [Abstract][Full Text] [Related]
39. The level of vascular endothelial growth factor as a predictor of a poor prognosis in osteosarcoma.
Kaya M; Wada T; Nagoya S; Sasaki M; Matsumura T; Yamashita T
J Bone Joint Surg Br; 2009 Jun; 91(6):784-8. PubMed ID: 19483233
[TBL] [Abstract][Full Text] [Related]
40. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution.
Bacci G; Mercuri M; Longhi A; Ferrari S; Bertoni F; Versari M; Picci P
Eur J Cancer; 2005 Sep; 41(14):2079-85. PubMed ID: 16115755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
